Pfizer Sees Ophthalmology Opportunity With NicOx’ Nitric Oxide-Donating Compound
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer will pay NicOx a total of €37 mil. if the compound becomes a commercialized product.